Circulating Free miRNAs as Liquid Biopsy Biomarkers for Early Detection of Breast Cancer in Peruvian Women
Cancers · 09.06.2026 · 18 (12) · 1883
DOI: 10.3390/cancers18121883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 09.06.2026. Verfasst von Diana J Arenas Machaca und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unidad Funcional de Genética y Biología Molecular, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica, Institute of Health Carlos III, Scientific Foundation of the Spanish Association Against Cancer.
Abstract (Originalsprache)
Background
Breast cancer is the most common cancer in women both in Peru and worldwide. Although mammography remains the standard for early detection, its effectiveness may be limited by unequal access to this technology. In this context, liquid biopsy emerges as a minimally invasive complementary technique that allows the identification of circulating biomarkers, such as microRNAs (miRNAs), whose differential expression has been associated with breast cancer.
Methods
The present study evaluated the diagnostic potential of cell-free circulating miRNAs for the early detection of breast cancer. In the screening phase, seven candidate miRNAs were quantified by qPCR in plasma from patients with early-stage breast cancer and healthy controls. In the validation phase, miR-191, miR-182, miR-335, and miR-125b were analyzed in an independent cohort of 30 untreated patients to evaluate their diagnostic performance. Results: miR-125b and miR-335 showed the best individual diagnostic performance, with AUCs of 0.81 and 0.78, respectively, and presented a significant moderate correlation (ρ = 0.608; p < 0.05), supporting their biological consistency and potential as complementary biomarkers. The multivariable binary logistic regression model that integrated both miRNAs showed a moderate improvement in discriminatory ability; however, the expanded multivariable model that incorporated the four validated miRNAs achieved an AUC of 0.91, with a sensitivity of 92% and a specificity of 90%.
Conclusions
The panel composed of miR-191, miR-182, miR-335, and miR-125b represents a promising set of circulating biomarkers for the early detection of breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unidad Funcional de Genética y Biología Molecular, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.
- Master's Program in Molecular Biology, Postgraduate Unit, Faculty of Biological Sciences, National University of San Marcos (UNMSM), Lima 15081, Peru.
- Institute of Biomedical Research, Hospital Universitario 12 de Octubre (IMAS12), 28041 Madrid, Spain.
- Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
- Grupo de Investigación de Bioquímica y Biología Sintética-UNFV (GIBBS-UNFV), Laboratorio de Bioquímica y Biología Molecular, Facultad de Ciencias Naturales y Matemática, Universidad Nacional Federico Villarreal (UNFV),…
ORCID-Profile: Diana J Arenas Machaca, Álvaro Martín de Bernardo, Daniel Alejandro Desposorio-Vicente, Sandro Casavilca-Zambrano, Bijaya Milagros García-Gómez, Juan Jose Contreras-Mancilla, Ruddy Liendo-Picoaga, Gustavo A Sandoval, Marta Dueñas Porto
Förderung
- Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
- Institute of Health Carlos III
- Scientific Foundation of the Spanish Association Against Cancer
- National Program for Scientific Research and Advanced Studies (PROCIENCIA) of the National Council for Science, Technology and Technological Innovation
- Instituto de Salud Carlos III
Zitieren
APA
Arenas Machaca, D. J., Martín de Bernardo, Á., Desposorio-Vicente, D. A., Casavilca-Zambrano, S., Cruz-Hualpa, K. Y., García-Gómez, B. M., Vidaurre, T., Sullcahuaman-Allende, Y., Contreras-Mancilla, J. J., Liendo-Picoaga, R., Sandoval, G. A., & Dueñas Porto, M. (2026). Circulating Free miRNAs as Liquid Biopsy Biomarkers for Early Detection of Breast Cancer in Peruvian Women. Cancers, 18(12), 1883. https://doi.org/10.3390/cancers18121883
Vancouver
Arenas Machaca DJ, Martín de Bernardo Á, Desposorio-Vicente DA, Casavilca-Zambrano S, Cruz-Hualpa KY, García-Gómez BM, et al. Circulating Free miRNAs as Liquid Biopsy Biomarkers for Early Detection of Breast Cancer in Peruvian Women. Cancers. 2026;18(12):1883. doi:10.3390/cancers18121883
BibTeX
@article{ArenasMachaca2026,
author = {Arenas Machaca, Diana J and Martín de Bernardo, Álvaro and Desposorio-Vicente, Daniel Alejandro and Casavilca-Zambrano, Sandro and Cruz-Hualpa, Karen Yoshira and García-Gómez, Bijaya Milagros and Vidaurre, Tatiana and Sullcahuaman-Allende, Yasser and Contreras-Mancilla, Juan Jose and Liendo-Picoaga, Ruddy and Sandoval, Gustavo A and Dueñas Porto, Marta},
title = {Circulating Free miRNAs as Liquid Biopsy Biomarkers for Early Detection of Breast Cancer in Peruvian Women},
journal = {Cancers},
year = {2026},
volume = {18},
number = {12},
pages = {1883},
doi = {10.3390/cancers18121883}
}
EUVIMED